Vulvovaginal Candidiasis (Candida albicans)
Overview
Plain-Language Overview
Vulvovaginal Candidiasis (Candida albicans) is a common infection affecting the vaginal area and surrounding tissues in women. It is caused by an overgrowth of the yeast Candida albicans, which normally lives in small amounts in the vagina without causing harm. When this yeast grows excessively, it leads to symptoms such as itching, burning, and a thick, white vaginal discharge. The infection primarily affects the female reproductive system and can cause significant discomfort. It is not considered a sexually transmitted infection but can be influenced by factors like antibiotics, diabetes, or hormonal changes. The condition is usually localized but can recur frequently in some women.
Clinical Definition
Vulvovaginal Candidiasis (VVC) is an inflammatory condition of the vulva and vagina caused by the overgrowth of the yeast Candida albicans. This yeast is part of the normal vaginal flora but can become pathogenic when the local immune defenses or vaginal microbiome are disrupted. The core pathology involves fungal invasion of the vaginal mucosa, leading to inflammation, erythema, and pruritus. VVC is characterized by a thick, curd-like vaginal discharge and vulvar irritation. It is a major cause of vaginitis and can significantly impair quality of life due to recurrent episodes. Predisposing factors include antibiotic use, immunosuppression, diabetes mellitus, and pregnancy. Diagnosis and management focus on identifying the yeast and differentiating it from other causes of vaginitis.
Inciting Event
Recent broad-spectrum antibiotic therapy is a common trigger for fungal overgrowth.
Hormonal fluctuations such as those during pregnancy or menstrual cycle can initiate infection.
Uncontrolled hyperglycemia in diabetes precipitates fungal proliferation.
Use of intravaginal products or irritants can disrupt mucosal barriers facilitating infection.
Latency Period
Symptoms typically develop within days to 1 week after the inciting event or trigger.
Fungal colonization may precede symptoms by several days before clinical infection manifests.
Diagnostic Delay
Symptom overlap with bacterial vaginosis or trichomoniasis often leads to misdiagnosis.
Empiric treatment without confirmatory testing delays accurate diagnosis and targeted therapy.
Failure to recognize recurrent or complicated cases can prolong time to diagnosis.
Clinical Presentation
Signs & Symptoms
Vulvar pruritus is the hallmark symptom.
Burning sensation and irritation of the vulva and vagina.
Thick, white, odorless vaginal discharge described as cottage cheese-like.
Dyspareunia and dysuria may occur due to mucosal inflammation.
Erythema and edema of the vulva and vaginal mucosa are common on exam.
History of Present Illness
Onset of intense vulvar pruritus and burning often precedes other symptoms.
Thick, white, curd-like vaginal discharge is characteristic and typically odorless.
Dysuria and dyspareunia commonly develop as infection progresses.
Symptoms often worsen during or after menses due to hormonal changes.
Past Medical History
Previous episodes of vulvovaginal candidiasis increase risk of recurrence.
History of diabetes mellitus is a significant predisposing factor.
Recent antibiotic or corticosteroid use is frequently reported.
Immunosuppressive conditions or therapies contribute to susceptibility.
Family History
No strong familial inheritance pattern is associated with vulvovaginal candidiasis.
Rare genetic defects in innate immunity (e.g., CARD9 deficiency) may predispose to recurrent infections.
Physical Exam Findings
Erythematous and edematous vulvar and vaginal mucosa with possible excoriations from scratching.
Thick, white, curd-like vaginal discharge adherent to the vaginal walls.
Absence of malodor helps differentiate from bacterial vaginosis.
Vulvar erythema and fissures may be present in severe cases.
Normal or mildly increased vaginal pH (typically <4.5) distinguishes it from other infections.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of vulvovaginal candidiasis is established by clinical presentation of vulvar itching, erythema, and characteristic thick white vaginal discharge. Microscopic examination of vaginal discharge using a wet mount or KOH preparation reveals budding yeast or pseudohyphae, which is confirmatory. Culture of vaginal secretions can be used if microscopy is inconclusive or in recurrent cases. The absence of bacterial pathogens and negative tests for other causes of vaginitis help exclude differential diagnoses. Diagnosis relies on the combination of typical symptoms and direct visualization of Candida organisms.
Pathophysiology
Key Mechanisms
Overgrowth of Candida albicans disrupts normal vaginal flora leading to infection.
Adherence of fungal hyphae to vaginal epithelial cells triggers local inflammation.
Host immune response involves neutrophil recruitment causing mucosal irritation and symptoms.
Altered vaginal pH favors fungal proliferation and virulence factor expression.
Biofilm formation by Candida enhances resistance to antifungal agents and persistence.
| Involvement | Details |
|---|---|
| Organs | Vagina is the main organ affected, where Candida albicans overgrowth causes symptoms of vulvovaginal candidiasis |
Vulva is involved in the clinical presentation with erythema, edema, and pruritus due to local fungal infection | |
| Tissues | Vaginal mucosa is the primary site of infection and inflammation in vulvovaginal candidiasis |
Epidermis of the vulva is involved in local immune defense and can show erythema and irritation during infection | |
| Cells | Neutrophils are recruited to the site of infection and mediate fungal clearance through phagocytosis and release of reactive oxygen species |
Epithelial cells of the vaginal mucosa provide a physical barrier and produce antimicrobial peptides against Candida albicans | |
Macrophages contribute to fungal clearance by phagocytosis and cytokine production to coordinate immune response | |
| Chemical Mediators | Interleukin-17 (IL-17) is a key cytokine promoting neutrophil recruitment and antifungal defense in vulvovaginal candidiasis |
Tumor necrosis factor-alpha (TNF-α) enhances inflammatory response and helps control fungal infection | |
Defensins are antimicrobial peptides secreted by epithelial cells that disrupt fungal cell membranes |
Treatments
Pharmacological Treatments
Fluconazole
- Mechanism:
Inhibits fungal cytochrome P450 enzyme 14-alpha-demethylase, disrupting ergosterol synthesis and fungal cell membrane integrity
- Side effects:
Hepatotoxicity
Gastrointestinal upset
Headache
- Clinical role:
First-line
Clotrimazole
- Mechanism:
Inhibits ergosterol synthesis by blocking 14-alpha-demethylase, leading to increased fungal cell membrane permeability
- Side effects:
Local irritation
Burning sensation
Allergic reaction
- Clinical role:
First-line
Miconazole
- Mechanism:
Disrupts fungal cell membrane by inhibiting ergosterol synthesis via 14-alpha-demethylase inhibition
- Side effects:
Local irritation
Pruritus
Burning
- Clinical role:
First-line
Nystatin
- Mechanism:
Binds to ergosterol in fungal cell membranes, creating pores that cause ion leakage and cell death
- Side effects:
Local irritation
Contact dermatitis
- Clinical role:
Second-line
Non-pharmacological Treatments
Maintain good genital hygiene with gentle cleansing and avoid irritants such as scented soaps or douches
Wear loose-fitting, breathable cotton underwear to reduce moisture and fungal growth
Manage underlying risk factors such as diabetes mellitus and immunosuppression to prevent recurrence
Prevention
Pharmacological Prevention
Prophylactic antifungal therapy with topical azoles in recurrent cases.
Use of fluconazole maintenance therapy for frequent relapses.
Avoidance of broad-spectrum antibiotics unless necessary to reduce fungal overgrowth.
Non-pharmacological Prevention
Maintaining good genital hygiene and keeping the area dry.
Avoiding tight-fitting synthetic clothing to reduce moisture retention.
Managing underlying diabetes mellitus with good glycemic control.
Avoiding irritants such as scented soaps, douches, and spermicides.
Using cotton underwear to promote ventilation and reduce fungal growth.
Outcome & Complications
Complications
Recurrent vulvovaginal candidiasis causing chronic symptoms.
Secondary bacterial infection from excoriations and mucosal breakdown.
Vulvar cellulitis in severe untreated cases.
Psychological distress due to chronic pruritus and discomfort.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Vulvovaginal Candidiasis (Candida albicans) versus Bacterial Vaginosis
Vulvovaginal Candidiasis (Candida albicans) | Bacterial Vaginosis |
|---|---|
Overgrowth of yeast, primarily Candida albicans | Overgrowth of anaerobic bacteria such as Gardnerella vaginalis |
Thick, white, curd-like discharge without strong odor | Thin, grayish-white discharge with fishy odor |
Pseudohyphae and budding yeast on KOH prep | Clue cells on wet mount |
Improves with azole antifungals such as fluconazole | Improves with metronidazole or clindamycin |
Vulvovaginal Candidiasis (Candida albicans) versus Trichomoniasis
Vulvovaginal Candidiasis (Candida albicans) | Trichomoniasis |
|---|---|
Fungal infection with Candida albicans | Infection with motile protozoan Trichomonas vaginalis |
Thick, white, curd-like discharge | Frothy, yellow-green vaginal discharge |
Pseudohyphae and budding yeast on KOH prep | Motile trichomonads on wet mount |
Prominent vulvar pruritus and irritation without strong odor | Often associated with vaginal itching and malodor |
Vulvovaginal Candidiasis (Candida albicans) versus Atrophic Vaginitis
Vulvovaginal Candidiasis (Candida albicans) | Atrophic Vaginitis |
|---|---|
Premenopausal or reproductive-age women | Postmenopausal women due to estrogen deficiency |
Thick, white, curd-like discharge | Thin, pale vaginal mucosa with scant discharge |
Severe vulvar itching and burning | Vaginal dryness and dyspareunia without intense pruritus |
Improves with antifungal agents | Improves with topical estrogen therapy |
Vulvovaginal Candidiasis (Candida albicans) versus Contact Dermatitis
Vulvovaginal Candidiasis (Candida albicans) | Contact Dermatitis |
|---|---|
No specific irritant exposure; fungal overgrowth | Recent exposure to irritants or allergens such as soaps or hygiene products |
Pruritus with thick white discharge and vulvar erythema | Pruritus with erythema and possible vesicles or scaling |
Improves with antifungal therapy | Improves with removal of irritant and topical corticosteroids |
Vulvovaginal Candidiasis (Candida albicans) versus Herpes Simplex Virus Infection
Vulvovaginal Candidiasis (Candida albicans) | Herpes Simplex Virus Infection |
|---|---|
Erythema and white curd-like vaginal discharge without vesicles | Painful vesicles and ulcers on vulva |
Intense vulvar itching and burning without systemic symptoms | Severe pain and dysuria with systemic symptoms possible |
Positive KOH prep showing pseudohyphae and budding yeast | Positive PCR or viral culture for HSV |